⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JSPR News
Jasper Therapeutics, Inc. Common Stock
Pomerantz LLP Moves Forward with Class Action Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
prnewswire.com
JSPR
Pomerantz LLP Launches Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR Deadline: Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders to Contact the Firm for Information About Their Rights
businesswire.com
JSPR
Pomerantz LLP Launches Securities Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR
prnewswire.com
JSPR
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
JSPR
Pomerantz LLP Launches Class Action Filing Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Jasper Therapeutics
businesswire.com
JSPR